Skip to main content

Constrictive Pericarditis Vs Restrictive Cardiomyopathy

 

Echocardiography for beginners


Constrictive Pericarditis (CP) vs Restrictive Cardiomyopathy (RCM)


Why this distinction matters


Both conditions present with right-sided heart failure, preserved or mildly reduced EF, normal or small ventricles, and elevated filling pressures. However, management and prognosis differ dramatically:


Constrictive pericarditis is potentially curable with pericardiectomy.


Restrictive cardiomyopathy is a myocardial disease, usually managed medically or with transplant consideration.




---


Definitions and Core Pathophysiology


Constrictive Pericarditis


Disease of the pericardium


Thickened, fibrotic, often calcified pericardium


Creates a non-compliant shell around the heart


Ventricular interaction and dissociation between intrathoracic and intracardiac pressures


Diastolic filling abruptly stops after early rapid filling



Restrictive Cardiomyopathy


Disease of the myocardium


Ventricular walls are stiff but not necessarily thick


Impaired ventricular relaxation and compliance


Intrathoracic pressure changes are normally transmitted to cardiac chambers


No pericardial constraint




---


Etiology


Constrictive Pericarditis


Idiopathic or post-viral (most common worldwide)


Tuberculosis (still important in South Asia)


Post-cardiac surgery


Post-radiation therapy


Chronic pericarditis


Connective tissue diseases



Restrictive Cardiomyopathy


Infiltrative: Amyloidosis (most common), sarcoidosis


Storage diseases: Hemochromatosis, Fabry disease


Endomyocardial fibrosis


Post-radiation myocardial fibrosis


Idiopathic




---


Clinical Features (Often Similar)


Feature CP RCM


Dyspnea Yes Yes

Peripheral edema Prominent Prominent

Ascites Common Common

JVP Elevated with rapid y descent Elevated, less prominent y descent

Kussmaul sign Common Can occur

Chest pain Rare Rare



Clinical examination alone is insufficient → imaging and hemodynamics are essential.



---


Echocardiography: The Most Important Non-Invasive Tool


Key Echo Findings in Constrictive Pericarditis


Septal bounce (early diastolic interventricular septal shift)


Marked respiratory variation:


Mitral E velocity ↓ ≥25% with inspiration


Tricuspid E velocity ↑ ≥40% with inspiration



Annulus paradoxus:


Medial e′ ≥ lateral e′



Preserved or exaggerated e′ velocities (myocardium is normal)


Dilated IVC with reduced collapse



Key Echo Findings in Restrictive Cardiomyopathy


No septal bounce


Minimal respiratory variation in mitral/tricuspid inflow


Reduced e′ velocities (impaired myocardium)


Biatrial enlargement (often massive)


Restrictive filling pattern (E/A > 2, short DT)




---


Tissue Doppler: The Decisive Clue


Parameter CP RCM


Medial e′ Normal or high (>8 cm/s) Reduced

Lateral e′ Reduced Reduced

Medial > Lateral Yes (annulus reversus) No

E/e′ Often normal Elevated



Normal or high e′ strongly favors constriction.



---


Cardiac MRI and CT


Constrictive Pericarditis


Pericardial thickness >4 mm


Pericardial calcification (best seen on CT)


Septal bounce on cine MRI


Lack of myocardial fibrosis



Restrictive Cardiomyopathy


Normal pericardium


Diffuse or focal myocardial late gadolinium enhancement


T1 mapping abnormalities (especially amyloidosis)




---


Cardiac Catheterization: Gold Standard When Doubt Persists


Hemodynamic Feature CP RCM


LV/RV diastolic pressures Equalized Elevated but not equal

Square root sign Present Present

Respiratory discordance Yes (LV ↓, RV ↑ with inspiration) No

Intrathoracic pressure transmission Absent Preserved



Respiratory discordance of LV and RV pressures is diagnostic of CP.



---


Laboratory Clues


BNP: Normal or mildly elevated in CP


BNP: Markedly elevated in RCM (Pericardial constraint limits wall stress in CP)




---


Management


Constrictive Pericarditis


Diuretics for symptom control


Treat underlying cause (e.g., TB therapy)


Definitive treatment: Complete pericardiectomy


Excellent outcomes if diagnosed early and myocardium is normal



Restrictive Cardiomyopathy


Diuretics (carefully)


Treat underlying etiology (e.g., amyloidosis-specific therapy)


Rate control in AF


Anticoagulation if AF or atrial enlargement


Advanced cases → heart transplantation




---


Prognosis


Condition Prognosis


CP Potentially curable

RCM Progressive, often poor



Early differentiation prevents missed surgical cure or unnecessary surgery.



---


One-Glance Comparison Table


Feature Constrictive Pericarditis Restrictive Cardiomyopathy


Primary pathology Pericardium Myocardium

Pericardial thickness Increased Normal

Septal bounce Present Absent

Respiratory variation Marked Minimal

Tissue Doppler e′ Normal/high Reduced

BNP Low–normal High

Surgical cure Yes No




---


Key Take-Home Messages


Think pericardium vs myocardium


Normal e′ excludes restrictive cardiomyopathy


Respiratory discordance = constriction


Missing CP means missing a cure



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.